Sharp Therapeutics Corp.
SHRX.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -96.68% | -94.81% | -72.55% | -- | 1,246.47% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -47.80% | -66.04% | 70.85% | -- | 112.84% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -95.37% | -93.03% | -71.15% | -- | 964.69% |
|
|
|||||
| Total Current Assets | -95.37% | -93.03% | -71.15% | -- | 964.69% |
| Net Property, Plant & Equipment | -9.57% | -11.66% | -9.65% | -- | -9.32% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | -- | 0.00% |
| Total Assets | -75.31% | -66.99% | -57.14% | -- | 203.93% |
|
|
|||||
| Total Accounts Payable | -22.61% | -26.91% | 8.39% | -- | -19.52% |
| Total Accrued Expenses | 494.21% | 587.29% | 119.46% | -- | -72.53% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 354.05% | 420.00% | 200.00% | -- | 55.16% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -100.00% |
| Total Other Current Liabilities | -- | -- | -- | -- | -100.00% |
| Total Current Liabilities | 327.58% | -14.24% | 38.39% | -- | -96.49% |
|
|
|||||
| Total Current Liabilities | 327.58% | -14.24% | 38.39% | -- | -96.49% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -17.44% | -18.37% | -8.25% | -- | -3.70% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 82.76% | -15.61% | 8.08% | -- | -88.91% |
|
|
|||||
| Common Stock & APIC | 5.43% | 17.22% | 15.39% | -- | 385.94% |
| Retained Earnings | -26.25% | -23.20% | -31.05% | -- | -14.86% |
| Treasury Stock & Other | -271.54% | -124.12% | -721.31% | -- | -- |
| Total Common Equity | -188.79% | -229.18% | -106.83% | -- | 116.93% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -188.79% | -229.18% | -106.83% | -- | 116.93% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -188.79% | -229.18% | -106.83% | -- | 116.93% |
|
|
|||||